Tri Chemical Laboratories Inc.

DB:22E Stock Report

Market Cap: €568.7m

Tri Chemical Laboratories Balance Sheet Health

Financial Health criteria checks 6/6

Tri Chemical Laboratories has a total shareholder equity of ¥28.8B and total debt of ¥1.7B, which brings its debt-to-equity ratio to 6%. Its total assets and total liabilities are ¥33.5B and ¥4.8B respectively. Tri Chemical Laboratories's EBIT is ¥2.8B making its interest coverage ratio 132.7. It has cash and short-term investments of ¥9.5B.

Key information

6.0%

Debt to equity ratio

JP¥1.73b

Debt

Interest coverage ratio132.7x
CashJP¥9.53b
EquityJP¥28.77b
Total liabilitiesJP¥4.76b
Total assetsJP¥33.53b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 22E's short term assets (¥19.7B) exceed its short term liabilities (¥3.2B).

Long Term Liabilities: 22E's short term assets (¥19.7B) exceed its long term liabilities (¥1.5B).


Debt to Equity History and Analysis

Debt Level: 22E has more cash than its total debt.

Reducing Debt: 22E's debt to equity ratio has reduced from 37.3% to 6% over the past 5 years.

Debt Coverage: 22E's debt is well covered by operating cash flow (59%).

Interest Coverage: 22E's interest payments on its debt are well covered by EBIT (132.7x coverage).


Balance Sheet


Discover healthy companies